Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $50.2M invested in Corvus Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.
Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
12
Reduced
10
Closed
7
Calls
$111K
Puts
$65K
Net Calls
+$46K
Net Calls Change
+$40K
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$10.9M |
| 2 |
SC
2
Samlyn Capital
New York
|
$11.1M |
| 3 |
3
Millennium Management
New York
|
$372K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$3M |
| 5 |
5
Morgan Stanley
New York
|
$676K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -2,378 | Closed |
|
52
Wells Fargo
San Francisco,
California
| – | – | -265 | Closed |
|
|
IGWM
53
ICA Group Wealth Management
Denver,
Colorado
| – | – | -165 | Closed |
|
|
CFGS
54
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
55
Barclays
London,
United Kingdom
| $0 | 1 | – | – |
|